It has been found that ALT-targeted NF-κB and the downstream signaling pathways inhibit the migration of breast cancer cells and trigger the apoptosis of chronical myeloid leukemia cells (Wei et al., 2013; Liu J. et al., 2018). Here, NFKB1 is linked to breast cancer.